Introduction The clinical and economic impact of cervical cancer consistently become a
serious burden for all countries, including Indonesia. The implementation of HPV …

Objectives: Cervical cancer (CC) had the second highest incidence of female cancers in
Malaysia in 2003-2006. Prevention is possible by both Pap smear screening and HPV …

Introduction: Cervical cancers (CC) demonstrate the second highest incidence of female
cancers in Malaysia. The costs of chronic management have a high impact on nation's …

Background: An estimated 70% of cervical cancers worldwide are attributable to persistent
infection with human papillomaviruses (HPV) 16 and 18. Vaccination against HPV 16/18 has …

Objective: National cervical cancer prevention program has been initiated in Indonesia since
April 2015 and the ministry of health has started efforts to integrate the HPV Vaccine in the …

Cervical cancer is the second most common cancer among women in the Philippines.
Human papillomavirus (HPV) vaccination provides protection from the most common cancer …

Objectives To estimate the cost effectiveness of introducing the quadrivalent human
papillomavirus (HPV) vaccine into the national immunization program of Iran. Methods The …

Background The HPV vaccine was introduced to Malaysian national immunization
programme in 2010. The current implementation age of HPV vaccination in Malaysian is at …

Background The purpose, methods, data sources and assumptions behind the World Health
Organization (WHO) Cervical Cancer Prevention and Control Costing (C4P) tool that was …

To date, no studies have evaluated the cost-effectiveness of human papillomavirus (HPV)
vaccination in countries in the Extended Middle East and North Africa (EMENA) region. We …